Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Obesity (Silver Spring). 2020 Sep 27;28(11):2116–2124. doi: 10.1002/oby.22975

Table 2.

Clinical Variables Across the Four Treatments Within the Stepped Care Treatment Group.

Post-treatment 6-month follow-up
BWL+Pla BWL+Med CBT+Pla CBT+Med BWL+Pla BWL+Med CBT+Pla CBT+Med
Variable M SD M SD M SD M SD M SD M SD M SD M SD
Binge episodes/month (EDE) 1.7 3.7 1.0 2.5 6.2 9.6 0.2 0.4 2.2 5.9 3.3 5.7 9.9 11.4 1.9 3.4
EDE Global Score 1.8 0.9 1.7 0.6 1.8 1.0 1.6 0.9 1.8 1.0 1.6 0.8 2.1 1.0 1.4 0.8
Depression (BDI) 7.9 6.2 7.5 5.7 15.1 13.4 7.4 4.9 8.4 6.2 7.0 6.4 14.1 10.5 6.9 5.1
Body mass index 37.1 5.5 34.9 5.5 40.6 5.6 36.3 5.0 37.9 7.0 35.0 6.6 40.6 5.8 37.3 5.4
Weight 230.8 50.0 215.2 38.5 257.5 49.5 233.7 40.3 234.5 54.9 219.8 49.1 260.8 49.5 240.0 41.2
% Wt Loss from Base −6.1 5.9 −8.6 7.0 −0.5 5.7 −4.6 8.4 −5.3 9.2 −8.2 10.2 −0.3 5.0 −2.9 12.1
% Wt Loss from Post -- -- -- -- -- -- -- -- 0.1 6.5 1.3 6.9 0.3 2.8 1.8 5.7
Waist Circumference 43.6 5.9 41.9 4.8 47.4 6.5 43.4 5.4 44.2 6.3 42.3 6.0 47.4 6.7 44.3 5.0
12-month follow-up
BWL+Pla BWL+Med CBT+Pla CBT+Med
Variable M SD M SD M SD M SD
Binge episodes/month (EDE) 2.2 5.0 2.7 5.5 4.3 6.4 0.6 1.1
EDE Global Score 1.6 1.0 1.6 0.7 2.0 0.9 1.5 1.0
Depression (BDI) 7.2 6.4 6.3 5.5 16.5 13.3 6.3 6.5
Body mass index 38.1 7.3 34.6 6.5 40.8 5.9 37.1 5.3
Weight 236.5 56.4 218.3 47.2 261.9 48.2 233.9 43.8
% Wt Loss from Base −6.3 9.8 −7.6 10.6 0.2 6.0 −2.3 12.7
% Wt Loss from Post −0.1 8.4 2.6 9.3 0.9 4.2 2.9 7.5
Waist Circumference 44.1 6.3 42.6 6.0 47.9 6.2 43.8 5.3

Note: M = mean. SD = standard deviation. EDE = Eating Disorder Examination. BDI = Beck Depression Inventory; Wt = Weight Within Stepped-care, the following specific treatment cells were created by the stratified randomization: BWL+Pla (N=46), BWL+Med (N=47; of these, N=22 with sibutramine and N=25 with orlistat), CBTgsh+Pla (N=25), and CBTgsh+Med (N=24; of these, N=16 with sibutramine and N=8 with orlistat).

HHS Vulnerability Disclosure